Elie F. Berbari, M.D., FIDSA
Chair, Infectious Diseases
Professor of Medicine, Infectious Diseases

Matthew J. Binnicker,  Ph.D.
Director of Clinical Virology
Professor of Laboratory Medicine and Pathology

Priya Sampathkumar,  M.D.
Associate Professor of Infectious Diseases

Elitza S. Theel,  Ph.D.
Director of Infectious Diseases Serology Laboratory
Associate Professor of Laboratory Medicine and Pathology

Locations:

• Geffen Auditorium Hall (Live)
• Broadcast to SMH Alfred M-459 and Baldwin 4-316/Baldwin 4-516

Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first-come, first-serve basis.

Learning Objectives:

• Describe how molecular testing for COVID-19 is performed at  Mayo Clinic
• Review the advantage and limitations of molecular testing for COVID-19
• Discuss performance characteristics of serologic testing performed at  Mayo Clinic

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.